In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 3777-3783

  Liu, Dijie ^a,c   Overbey, Douglas ^a   Watkinson, Lisa D ^a,c   Daibes Figueroa, Said ^a,c   Hoffman, Timothy J ^a,b,c   Forte, Leonard R ^a,b,c   Volkert, Wynn A ^a,b,c   Giblin, Michael F ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Colorectal cancer; E. Coli heat stable enterotoxin; Guanylyl cyclase C; In vivo imaging; Single photon emitting computed tomography (SPECT); Uroguanylin

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID E3 UROGUANYLIN IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID UROGUANYLIN IN 111; ASPARTIC ACID; E3 UROGUANYLIN; ESCHERICHIA COLI ENTEROTOXIN; GLUTAMIC ACID; GUANYLATE CYCLASE C RECEPTOR; INDIUM 111; IODINE 125; MEMBRANE RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR A; PEPTIDE HORMONE; UNCLASSIFIED DRUG; UROGUANYLIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER DIAGNOSIS; CELL CYCLE ARREST; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; DRUG UPTAKE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IC 50; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCID MOUSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERMOSTABILITY; TUMOR LOCALIZATION; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; COLORECTAL NEOPLASMS; FEMALE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INDIUM RADIOISOTOPES; MICE; MICE, INBRED ICR; MICE, SCID; MOLECULAR SEQUENCE DATA; NATRIURETIC PEPTIDES; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, HETEROLOGOUS;

EID: 71949097117     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Guarino A, Cohen M, Thompson M, Dharmsathaphorn K and Giannella R: T84 cell receptor binding and guanyl cyclase activation by Escherichia coli heat-stable toxin. Am J Physiol 253: G775-G780, 1987.
2. Vaandrager AB, Schulz S, De Jonge HR and Garbers DL: Guanylyl cyclase C is an N-linked glycoprotein receptor that accounts for multiple heat-stable enterotoxin-binding proteins in the intestine. J Biol Chem 268: 2174-2179, 1993. (Pubitemid 23033630)
3. Guarino A, Cohen M, Overmann G, Thompson M and Giannella R: Binding of E. coli heat-stable enterotoxin to rat intestinal brush border and basolateral membranes. Dig Dis Sci 32: 1017-1026, 1987. (Pubitemid 17137984)
4. Carrithers SL, Parkinson SJ, Goldstein S, Park P, Robertson DC and Waldman SA: Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterology 107: 1653-1661, 1994. (Pubitemid 124006525)
5. Carrithers SL, Parkinson SJ, Goldstein SD, Park P, Urbanski RW and Waldman SA: Escherichia coli heat-stable enterotoxin receptors: A novel marker for colorectal tumors. Dis Colon Rectum 39: 171-181, 1996. (Pubitemid 26050896)
6. Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD and Waldman SA: Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci USA 93: 14827-14832, 1996. (Pubitemid 26419054)
7. Cohen MB, Hawkins JA and Witte OP: Guanylin RNA expression in human intestine and colorectal adenocarcinoma. Lab Invest 78: 101-108, 1998. (Pubitemid 28074313)
8. Steinbrecher KA, Tuohy TM, Heppner Goss K, Scott MC, Witte DP, Groden J and Cohen MB: Expression of guanylin is downregulated in mouse and human intestinal adenomas. Biochem Biophys Res Commun 273: 225-230, 2000. (Pubitemid 30426891)
9. Shailubhai K, Yu HH, Karunanandaa K, Wang JY, Eber SL, Wang Y, Joo NS, Kim HD, Miedema BW, Abbas SZ, Boddupalli SS, Currie MG et al: Uroguanylin treatment suppresses polyp formation in the ApcMin/+ mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP. Cancer Res 60: 5151-5157, 2000. (Pubitemid 30739773)
10. Waldman SA, Hyslop T, Schulz S, Barkun A, Nielsen K, Haaf J, Bonaccorso C, Li Y and Weinberg DS: Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. JAMA 301: 745-752, 2009.
11. 111In-labeled ST-peptide enterotoxin (ST) analog for specific targeting of guanylin receptors on human colonic cancers. Anticancer Res 21: 2785-2792, 2001. (Pubitemid 33054456)
12. Wolfe HR, Mendizabal M, Lleong E, Cuthbertson A, Desai V, Pullan S, Fujii DK, Morrison M, Pither R and Waldman SA: In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C-specific ligand. J Nucl Med 43: 392-399, 2002.
13. 111In-DOTA group and distinct linker moieties. Bioconj Chem 15: 872-880, 2004.
14. Giblin MF, Sieckman GL, Watkinson LD, Daibes-Figueroa S, Hoffman TJ, Forte LR and Volkert WA: Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells. Anticancer Res 26: 3243-3252, 2006. (Pubitemid 44701492)
15. 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers. Nucl Med Biol 33: 481-488, 2006.
16. Shailubhai K: Therapeutic applications of guanylate cyclase-C receptor agonists. Curr Opinion Drug Disc Dev 5: 261-268, 2002.
17. Saha S, Chowdhury P, Pal A and Chakrabarti MK: Downregulation of human colon carcinoma cell (COLO-205) proliferation through PKG-MAP kinase mediated signaling cascade by E. coli heat stable enterotoxin (STa), a potent anti-angiogenic and anti-metastatic molecule. J Appl Toxicol 28: 475-483, 2008. (Pubitemid 351716532)
18. Camici M: Guanylin peptides and colorectal cancer. Biomed Pharmacother 62: 70-76, 2008.
19. Li P, Schulz S, Bombonati A, Palazzo JP, Hyslop TM, Xu Y, Baran AA, Siracusa LD, Pitari GM and Waldman SA: Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity. Gastroenterology 133: 599-607, 2007. (Pubitemid 47187356)
20. Kloeters O, Friess H, Giese N, Buechler MW, Cetin Y and Kulaksiz H: Uroguanylin inhibits proliferation of pancreatic cancer cells. Scand J Gastroenterol 43: 447-455, 2008.
21. Hamra FK, Forte LR, Eber SL, Pidhorodeckyj NV, Krause WJ, Freeman RH, Chin DT, Tompkins JA, Fok KF, Smith CE, Duffin, KL, Siegel, NR et al: Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci USA 90: 10464-10468, 1993. (Pubitemid 23347062)
22. Hamra FK, Eber SL, Chin DT, Currie MG and Forte LR: Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity. Proc Natl Acad Sci USA 94: 2705-2710, 1997.
23. Forte LR: Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol Ther 104: 137-162, 2004. (Pubitemid 39424257)
24. Carrithers SL, Ott CE, Hill MJ, Johnson BR, Cai W, Chang JJ, Shah RG, Sun C, Mann EA, Fonteles MC, Forte LR, Jackson BA et al: Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor. Kidney Int 65: 40-53, 2004. (Pubitemid 38037490)
25. Sindiće A, Başoglu C, Cerçi A, Hirsch JR, Potthast R, Kuhn M, Ghanekar Y, Visweswariah SS and Schlatter E: Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells. J Biol Chem 277: 17758-17764, 2002. (Pubitemid 34967582)
26. Elitsur N, Lorenz JN, Hawkins JA, Rudolph JA, Witte D, Yang LE, McDonough AA and Cohen MB: The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response. J Pediatr Gastroenterol Nutr 43(Suppl 1): S74-S81, 2006. (Pubitemid 44014982)
27. Pitari GM, Baksh RI, Harris DM, Li P, Kazerounian S and Waldman SA: Interruption of homologous desensitization in cyclic guanosine 3′,5′-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins. Cancer Res 65: 11129-11135, 2005. (Pubitemid 41713384)
28. Pitari GM, Di Guglielmo MD, Park J, Schulz S and Waldman SA: Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci USA 98: 7846-7851, 2001. (Pubitemid 32642649)
29. Pitari GM, Zingman LV, Hodgson DM, Alekseev AE, Kazerounian S, Bienengraeber M, Hajnoczky G, Terzic A and Waldman SA: Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci USA 100: 2695-2699, 2003. (Pubitemid 36297561)
30. Tian X, Michal AM, Li P, Wolfe HR, Waldman SA and Wickstrom E: STa peptide analogs for probing guanylyl cyclase C. Biopolymers 90: 713-723, 2008.